Weight-loss and diabetes drugs dominated pharmaceutical spending last year, according to a new report by the American Society of Health-System Pharmacists, who warns of tariff-driven supply chain threats and continued growth in clinic drug costs.

A well-defined scientific and strategic approach is critical for buyers in this dealmaking setting.

The 700,000 square-foot facility is expected to create 400 high-wage manufacturing jobs once operational.

The order pushes drug companies to reduce drug prices in the United States to fall in line with other countries around the world.

Identifying the priorities that translate to strong business outcomes—and separating the top performers from the average brands.

The President plans to sign an executive order on Monday morning to enforce the trade clause.

Merck Animal Health will invest $895 million to expand vaccine manufacturing and R&D in Kansas, while Lilly is committing $250 million to pharmaceutical innovation and workforce development through its extended partnership with Purdue University.

Proposed cuts to Medicaid could cause serious issues in rural areas of the United States.

Navigating technology and regulatory shifts in pharma revenue management.

The Avmapki Fakzynja Co-Pack marks the first FDA-approved treatment for adult patients with KRAS-mutated recurrent low-grade serous ovarian cancer who have received prior systemic therapy.

Five steps for organizations in bringing enterprise-level strategies to life.

Josh Marsh, Vice President and General Manager of Cardinal Health Sonexus™ Access and Patient Support, outlines the recent shift in the patient services industry towards a hybrid hub model for in-house management and outsourced support.

Armando Castro, partner, emerging companies, venture capital, Lowenstein Sandler, explains how regulatory, patent, and reimbursement challenges are slowing venture investment in GLP-1 and psychedelic addiction therapies.

The provider hopes that this option will be a solution to the state’s primary care physician shortage.

The use of RWD data in place of placebo groups is improving various elements across the clinical trial space.

The company shifted several key presidents to adjust its global priorities.

Interim results from the ongoing Phase III ASSURE trial demonstrated that Livdelzi maintained a consistent biochemical response in patients with primary biliary cholangitis.

Founder and CEO of Alume Biosciences, Quyen Nguyen, MD, PhD, discusses nerve regeneration, nerve visualization and the reason behind what she does at Alume Biosciences.

Country is poised to offer growth-channel opportunities for global pharma companies ready to scale access, innovation, and profitability.

Commissioner Markary announced the plans alongside the results of a generative AI pilot for scientific reviewers.

Top-line results from two pivotal Phase III trials found that MR-107A-02 significantly reduced pain intensity following herniorrhaphy and bunionectomy surgeries compared to placebo.

The argument for weighing clinical points more heavily in the access equation.

The pharma tech company announced a deal with Starvision to roll out its services across the network over the next five years.

The growing complexity of supply chains necessitates the adoption of collaborative planning processes and capabilities such as S&OP and S&OE.

The program will send 11 young soccer players to learn from professional soccer coaches in Madrid.